Scope
The National Cancer Grid pathway organizes cancer-pain care by pain mechanism and severity. It combines analgesia with investigation for urgent causes, cancer-directed treatment where appropriate, specialist procedures and practical support for patients and caregivers.
Written by House with AI assistance · AI-assisted source check 29 October 2026.
This is House’s summary of the cited guidance. The source check is not an independent clinician review. Open the publication for complete recommendations, exceptions, evidence grades and later amendments.
Identify the mechanism and urgent cause
- Use the history, examination and available investigations to distinguish somatic, visceral, neuropathic, bone and mixed pain. The pathway describes somatic pain as superficial and localized, visceral pain as deeper and poorly localized, and neuropathic pain as shooting, burning or electric-shock-like. [1]
- For somatic pain, decide whether further investigation is needed to exclude emergencies such as fracture. Start analgesia before arranging cancer-directed referral when the cause is amenable to radiotherapy, medical oncology or surgery. [1]
- For visceral pain, assess for urgent causes including malignant bowel obstruction or obstructive uropathy, while providing analgesia and arranging appropriate cancer-directed care. [1]
- When neuropathic pain is suspected, use history, examination, screening tools such as S-LANSS and imaging as appropriate. Consider further CT or MRI to assess malignant plexus involvement or spinal-cord compression. [1]
- In bone pain, investigate possible malignant fracture or impending cord compression, and initiate analgesia according to severity. Cancer-directed referrals may include radiotherapy, oncology or radionuclide treatment; the pathway also lists denosumab and intravenous zoledronic acid. [1]
Match analgesic intensity and setting to need
- For mild somatic pain, the outpatient tier uses non-opioid medication with optional adjuvant analgesia and supportive care. Moderate-to-severe pain moves to opioids, with adjuvants and interventional pain management as appropriate. [1]
- Severe somatic pain or a pain crisis is managed in the inpatient tier with titrated parenteral opioid treatment and additional adjuvant, interventional and supportive measures as indicated. [1]
- Neuropathic pain management emphasizes adjuvant analgesics. More severe disease may need combinations, opioids and specialist intervention; a crisis requires inpatient escalation rather than an unmonitored outpatient infusion protocol. [1]
- For mixed pain, treat the contributing mechanisms, investigate red flags and consider cancer-directed referral. The pathway escalates from non-opioid/adjuvant treatment to opioids and, in a crisis, inpatient intravenous titration and interventional review. [1]
Anticipate medication risk and seek specialist input
- Before NSAIDs, assess comorbidities, current medicines and allergies. The source advises avoiding them in cardiovascular disease, renal dysfunction, coagulation disorders or acid-peptic disease, using the lowest effective dose for the shortest duration and maintaining hydration. [1]
- Provide gastroprotection with NSAIDs as described in the source, and monitor renal function if treatment extends beyond a few days. The pathway notes that renal toxicity remains relevant for both COX-1 and COX-2 inhibitors. [1]
- Seek specialist pain intervention for pain refractory to a medication trial, uncontrolled medication adverse effects, or when pharmacotherapy is unsuitable. Options in the procedure lists include nerve or plexus blocks, neuraxial techniques and specialist infusions. [1]
Teach regular treatment and address functional needs
- Educate the patient and caregiver about regular analgesic and breakthrough doses, adverse effects, and use of laxatives or antiemetics with opioids. Encourage timely dosing, a daily pain diary and review when pain persists despite medication. [1]
- Use multidisciplinary support: physiotherapy or occupational therapy for movement, energy conservation, positioning and assistive devices; psycho-oncology for distress; and dietetic advice for swallowing-related difficulty. [1]
- Consider supportive equipment appropriate to the pain and disability, including walking aids to limit weight bearing, braces or splints, TENS and ambulatory infusion devices. [1]
Limitations and use
- This is the NCG pain pathway released in May 2021. Its detailed drug table contains incomplete or unclear unit and dosing entries, so this summary does not reproduce that table as a complete prescribing or opioid-conversion protocol. Procedural and opioid titration choices require the relevant specialist context; missing doses and safety details must not be inferred from this overview.
This summary is selective and does not reproduce every recommendation. Apply the source’s population, setting and eligibility criteria, together with clinical judgement and local policy.
Summary sources
- Approach to managing Pain in cancer patient
Selected recommendation material consulted
Publication details
- Issuing organisation
- NCG
- Resource type
- Clinical guideline · House clinical summary
- Source setting
- India
The source check confirms publication details and the linked edition. It does not certify every recommendation or its suitability for an individual patient. Publisher access conditions may apply.